Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.46 |
| ▸ | GABRD | O14764 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.46 |
| ▸ | GABRE | P78334 | 1/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.46 |
| ▸ | GSK3A | P49840 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25714662 | 0.89 | GABRP (0.41) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL14752143 | 0.85 | GPR3 (0.44) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL25714764 | 0.84 | GABRP (0.39) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL13245714 | 0.84 | GABRP (0.40) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL24055542 | 0.81 | GABRP (0.37) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL25461715 | 0.80 | GPR3 (0.45) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL25462901 | 0.79 | MEN1 (0.50) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL13021722 | 0.79 | GPR3 (0.44) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL25463033 | 0.78 | NPC1 (0.39) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL13021723 | 0.77 | GPR3 (0.39) | GPR3GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105820192-B | Metal complexes comprising novel ligand structures | 通用显示公司 | 2020-04-07 | — | — | CN | disclosed |
| US-9359549-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9359549-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9359549-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-06-07 | — | — | US | disclosed |
| EP-2417215-B1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORP (US) | 2014-05-07 | — | — | EP | disclosed |
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| EP-2417215-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | Universal Display Corporation (US) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010118029-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010118029-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | ZFX, VDAC1, PDCD1LG2 | GPR3 3470/4885GABRP 288/4885GABRD 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.